CIBC Private Wealth Group LLC Has $645,000 Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

CIBC Private Wealth Group LLC decreased its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 69,992 shares of the pharmacy operator’s stock after selling 5,743 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Walgreens Boots Alliance were worth $645,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in Walgreens Boots Alliance by 2.7% during the 4th quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock valued at $805,506,000 after acquiring an additional 2,279,495 shares in the last quarter. State Street Corp boosted its holdings in shares of Walgreens Boots Alliance by 18.0% during the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after purchasing an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. grew its position in Walgreens Boots Alliance by 19.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after purchasing an additional 2,185,950 shares in the last quarter. Norges Bank acquired a new position in Walgreens Boots Alliance in the 4th quarter valued at approximately $58,241,000. Finally, Bank of New York Mellon Corp lifted its position in Walgreens Boots Alliance by 9.6% in the 4th quarter. Bank of New York Mellon Corp now owns 5,432,383 shares of the pharmacy operator’s stock worth $50,684,000 after buying an additional 478,061 shares in the last quarter. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Price Performance

Shares of Walgreens Boots Alliance stock opened at $10.68 on Friday. Walgreens Boots Alliance, Inc. has a 1-year low of $8.08 and a 1-year high of $19.48. The firm has a fifty day simple moving average of $10.75 and a 200-day simple moving average of $9.97. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $9.23 billion, a price-to-earnings ratio of -1.04, a PEG ratio of 1.31 and a beta of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. The company had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.66 earnings per share. On average, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on WBA. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and dropped their price target for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Truist Financial dropped their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Bank of America boosted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Royal Bank of Canada raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Finally, StockNews.com started coverage on shares of Walgreens Boots Alliance in a research report on Thursday. They issued a “hold” rating for the company. Four investment analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Walgreens Boots Alliance has a consensus rating of “Hold” and a consensus target price of $10.59.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.